New diabetes combo drug passes early safety check in healthy volunteers
NCT ID NCT07304726
First seen Jan 09, 2026 · Last updated May 16, 2026 · Updated 18 times
Summary
This early-stage study tested a new combination diabetes drug called CKD-383 in 30 healthy adults. The goal was to see how the body processes the drug and if it is safe. Participants took the drug in two different ways to compare results. This study does not directly treat diabetes but helps researchers understand the drug better before testing it in patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H Plus Yangji Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.